JonesTrading Downgrades Kezar Life Sciences to Hold
Portfolio Pulse from Benzinga Newsdesk
JonesTrading analyst Catherine Novack has downgraded Kezar Life Sciences (NASDAQ:KZR) from Buy to Hold.
October 05, 2023 | 8:34 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Kezar Life Sciences has been downgraded from Buy to Hold by JonesTrading.
The downgrade from Buy to Hold by JonesTrading indicates a less optimistic outlook for Kezar Life Sciences. This could potentially lead to a decrease in the stock's price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100